5SCL
Structure of liver pyruvate kinase in complex with anthraquinone derivative 1
Summary for 5SCL
Entry DOI | 10.2210/pdb5scl/pdb |
Group deposition | ADP-competitive inhibitors of PKL (G_1002224) |
Descriptor | Pyruvate kinase, 1,6-di-O-phosphono-beta-D-fructofuranose, OXALATE ION, ... (7 entities in total) |
Functional Keywords | pyruvate kinase, active site, inhibition, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) More |
Total number of polymer chains | 8 |
Total formula weight | 392136.98 |
Authors | Lulla, A.,Foller, A.,Nain-Perez, A.,Grotli, M.,Brear, P.,Hyvonen, M. (deposition date: 2021-12-01, release date: 2022-03-16, Last modification date: 2024-05-22) |
Primary citation | Nain-Perez, A.,Foller Fuchtbauer, A.,Haversen, L.,Lulla, A.,Gao, C.,Matic, J.,Monjas, L.,Rodriguez, A.,Brear, P.,Kim, W.,Hyvonen, M.,Boren, J.,Mardinoglu, A.,Uhlen, M.,Grotli, M. Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase. Eur.J.Med.Chem., 234:114270-114270, 2022 Cited by PubMed: 35290845DOI: 10.1016/j.ejmech.2022.114270 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.134 Å) |
Structure validation
Download full validation report